Rocket Lab Corporation (NASDAQ: RKLB) — A Great Company Priced for the Whole Block to Gentrify

Independent equity research — fundamental analysis Date: 2026-06-10 Analyst coverage: Fresh initiation Price (intraday, 2026-06-10): ~$108 · Shares out (10-Q cover, 30-Apr-2026): ~578.8M · Market cap: ~$62.6B · Enterprise value: ~$61.4B FY end: December · Sector: Industrials — Aerospace & Defense (space launch & space systems)

⚡ Claude’s Take

This block is the author’s own independent opinion and general information only — not investment advice. The analysis that follows it is deliberately position-free and carries no price target; the only directional view expressed anywhere in this article is in this block.

Verdict: AVOID at this price — a genuinely great company at a deeply unforgiving price. HOLD if owned with conviction; not a short. Accumulate only on a major (40%+) drawdown. Directional entry zone where the risk/reward turns interesting: roughly $45–60 (an EV around $28–38B, ~40–55x TTM sales), and a “back up the truck” zone only below ~$40. At ~$108 you are paying ~90x trailing revenue for a company that lost ~$198M last year, burned ~$322M of cash, and whose entire incremental thesis rests on a rocket — Neutron — that has never flown and just ruptured a fuel tank on a test stand.

Tag: “The best house on a street that’s already priced for the whole block to gentrify.”

Rocket Lab is, after SpaceX, the most credible vertically-integrated space company in the Western world. The engineering is real, the Electron franchise is the only reliable high-cadence small-launch vehicle on Earth, the Space Systems business is winning prime contracts (SDA Tranche 3, $816M) that used to be the exclusive preserve of Lockheed and Northrop, and management executes. None of that is the problem. The problem is arithmetic. At ~$61.4B EV the market has already capitalized 5+ years of flawless, multi-front execution: Neutron flying and proving reusability, Space Systems scaling to platform margins, Golden Dome/SDA money converting to production, and an eventual services business that management itself calls premature to discuss. My reverse-DCF says even a strong bull case — revenue 8x to $5B by 2030 at an 18% FCF margin and a rich 15x exit — produces only ~$75B of EV, barely a market return from here; ~75–80% of today’s EV is Neutron and optionality, not the in-hand business. The “cheap vs. SpaceX” argument is false: SpaceX is IPO’ing at ~$1.75T on ~$18.7B of revenue — ~93x sales, essentially the same multiple — but with a flying reusable fleet and Starlink cash flow RKLB lacks. What flips me bullish: a clean Neutron orbital flight and a successful booster reuse on Flight 2, at ASPs that hold ~$50–55M — that de-risks the 80% of EV that is currently faith. What flips me bearish (beyond valuation): another multi-quarter Neutron slip or a Flight-1 loss, or gross margin stalling below ~40% as low-margin SDA work dominates the mix. Conviction: medium. The franchise quality is high-conviction; the price is the whole argument. I would rather own the business 40% lower and let someone else pay for the optionality.

1. Executive Summary

Rocket Lab Corporation is a vertically-integrated space company with two reportable segments: Launch Services (33% of FY2025 revenue) — the Electron small-launch vehicle, the suborbital HASTE hypersonics variant, and the in-development Neutron medium-lift rocket — and Space Systems (67%) — satellite manufacturing, spacecraft components (reaction wheels, star trackers, solar cells, separation systems, flight software, optical/laser-comms terminals, EO/IR payloads), and the Photon spacecraft platform. The company has compounded revenue at ~76% annually over five years, from ~$35M (2020) to $601.8M (FY2025) and a ~$680M trailing-twelve-month run-rate, with consolidated GAAP gross margin expanding from ~21% (FY2023) to 38% (Q1 2026).

The business is not yet profitable and is deeply cash-consumptive. FY2025 produced an operating loss of $228.8M, a net loss of $198.2M, and free cash outflow of $321.8M. The principal cause is research-and-development spend of $270.7M (45% of revenue), almost entirely Neutron. The cash burn is funded not by the balance sheet but by relentless equity issuance — roughly $1.6B of at-the-market and forward equity in the last ~15 months — which has lifted the share count by more than 20% in 18 months.

The investment debate is not about company quality; it is about price. On essentially every constituency — sell-side, retail, and skeptics — there is broad agreement that RKLB is the best-executing Western pure-play in space. The disagreement is whether ~$61.4B of enterprise value, ~90x trailing revenue, with ~75–80% of that value attributable to an unflown rocket and longer-dated optionality, already prices in a near-flawless outcome. Management’s own track record on the one variable that matters most — Neutron’s maiden flight — is a multi-year pattern of slippage (2024 → 2025 → mid-2026 → now Q4 2026), punctuated by a January 2026 first-stage tank rupture on a hydrostatic test.

This analysis takes no position and sets no price target. It concludes that RKLB is a structurally advantaged, well-managed franchise operating in attractive destination markets (medium launch and defense space systems) but in the shadow of a generational, now-public SpaceX; that its moat is real but emerging, concentrated in Space Systems vertical integration rather than launch, and partly acquired rather than organically built; and that the current valuation embeds expectations that the company’s own execution history makes far from certain. The asymmetry from here is skewed to the downside: consensus price targets sit at roughly the current price, short interest is a modest ~5.8% of float (no crowded short to squeeze), and the single largest line item — Neutron — is binary.

2. Business Overview

2.1 What the company does

Rocket Lab Corporation (renamed from “Rocket Lab USA, Inc.” in early 2026 to reflect international expansion) is an end-to-end space company headquartered in Long Beach, California, with launch sites in New Zealand (Launch Complex 1, two pads) and Wallops Island, Virginia (Launch Complex 2). It employs ~2,600 people. Founded in 2006 by New Zealander Peter Beck, who remains CEO and Chairman, the company went public via a SPAC merger (Vector Acquisition Corp) in August 2021.

The company reports two segments:

Launch Services (FY2025 revenue $199.0M, 33% of total, +59% YoY).

• Electron — a small-lift orbital rocket (~300 kg to LEO), the workhorse. As of FY2025, Rocket Lab had flown ~70+ Electron missions and is targeting its 100th launch in 2026 — the fastest cadence to a century in industry history. Average selling price has risen from ~$5–6M at introduction to ~$8.5M for commercial missions today. The factory is designed for up to 52 Electrons per year; 2025 saw a record 21 combined Electron/HASTE missions.
• HASTE (Hypersonic Accelerator Suborbital Test Electron) — a suborbital variant for hypersonic flight testing, now a fast-growing defense leg. A $190M, 20-launch block buy via Kratos under the MACH-TB program is the largest single order in that program; Anduril booked three dedicated HASTE launches in Q1 2026. HASTE is now nearly one-third of total launch backlog.
• Neutron — an in-development reusable medium-lift rocket (~13,000 kg to LEO reusable; ~15,000 kg expendable). No Neutron has flown. First flight is targeted for Q4 2026 (see the Competitive Position and Changes sections). Neutron is the central pillar of the equity thesis and the destination for the bulk of R&D spend.

Space Systems (FY2025 revenue $402.8M, 67% of total, +32% YoY).

• Satellite/spacecraft manufacturing — complete spacecraft builds, anchored by two Space Development Agency (SDA) prime contracts: a Transport Layer Tranche 2 award (~$515M) and a Tracking Layer Tranche 3 award ($816M, signed December 2025 — the largest contract in company history, up to ~$1B with merchant-component capture). The Photon bus is the in-house spacecraft platform (used on NASA’s CAPSTONE lunar mission and the ESCAPADE Mars mission).
• Merchant components/subsystems — a portfolio assembled largely through acquisition: reaction wheels and star trackers (Sinclair Interplanetary, 2020), flight software (Advanced Solutions, 2021), separation systems (Planetary Systems Corp, 2021), space-grade solar cells/arrays (SolAero, 2022), EO/IR payloads (GEOST, 2025), optical/laser inter-satellite-link terminals (Mynaric, closed April 2026), space optics (OSI, 2026), and precision robotics/solar-array-drive mechanisms (Motiv, announced 2026). Plus organically developed electric propulsion (Gauss thrusters).

A structurally important feature: Rocket Lab is both a merchant supplier to, and a prime competitor against, the legacy primes. Lockheed Martin is a greater-than-10% accounts-receivable customer for components, even as Rocket Lab competes with Lockheed and Northrop for the satellite prime awards. Management’s framing — “even when we lose, we win” — is that losing a prime competition still yields component purchase orders from the winner.

2.2 How it makes money; revenue character

Revenue is predominantly program- and milestone-based, and lumpy. Launch revenue mixes point-in-time recognition (launch completion) and over-time recognition (HASTE, certain government work) and is inherently uneven quarter to quarter. Space Systems is dominated by large, multi-year fixed-price government programs (SDA) whose revenue follows a back-loaded recognition curve gated by subcontractor delivery. The genuinely recurring-like layer is the merchant components business (repeat “quick-turn” orders) and bulk-buy launch contracts. There is no subscription or services revenue today; management’s eventual “services from space” / own-constellation ambition is explicitly deferred until Neutron is flying.

2.3 Backlog

Total backlog stood at ~$2.0–2.2B at Q1 2026 (up ~108% year-over-year), split roughly 41.5% Launch / 58.5% Space Systems. Approximately 36% of backlog is expected to convert to revenue within 12 months (~$790M), implying a trailing book-to-bill well above 1.0x and giving meaningful, if back-loaded, forward visibility.

Verdict (Business Overview): A genuinely differentiated, vertically-integrated space platform with two complementary engines — a reliable small-launch franchise generating cash contribution today, and a fast-growing, defense-weighted Space Systems business that is now the larger segment. The revenue base is real and accelerating, but its character is lumpy, government-concentrated, and not yet recurring; the highest-value pieces (Neutron, services) are prospective.

3. Industry Dynamics

3.1 Market structure and profit pools

The space economy that Rocket Lab addresses splits into three distinct sub-markets with very different structural attractiveness.

Small-lift launch — structurally unattractive. The dedicated small-launch market is small (~$3.5B in 2023, projected ~$5.8B by 2030, ~7% CAGR) and is structurally capped by rideshare. SpaceX’s Transporter/Bandwagon rideshare missions deliver a smallsat to a standard sun-synchronous orbit for a fraction of the cost of a dedicated Electron. Electron’s differentiation is genuine — specific orbit, schedule control, and responsiveness (“buying certainty,” in management’s words) — but it confines the dedicated small-launch pool to customers who genuinely need those attributes. The countervailing positive: the competitive field has collapsed. Astra, ABL, and Virgin Orbit have failed or exited; per CEO Beck, no new US or European small-launch vehicle reached orbit successfully in 2025. Electron is therefore the clear leader of a small pie.

Medium/heavy-lift launch — structurally attractive but brutally concentrated. The medium/heavy market is far larger (~$15.6B in 2024, projected ~$32B by 2030, ~12–13% CAGR) and is where Neutron is aimed. But independent analyses suggest the medium class realistically supports only ~3 viable vehicles at scale by 2030 — a concentrated oligopoly. The incumbent is SpaceX’s Falcon 9 (reusable, ~$2,500–3,000/kg effective), with Starship threatening to collapse $/kg further. Challengers include Blue Origin’s New Glenn (which suffered a pad-test explosion in May 2026), ULA’s Vulcan (the national-security workhorse), and Firefly/Northrop’s Eclipse (first flight ~2027). A profitable #2/#3 slot is plausible; price leadership is not.

Defense Space Systems — structurally attractive and the real prize. The largest and fastest-growing pool, and where government money is flowing: proliferated-LEO constellations (SDA Transport and Tracking Layers), missile warning/tracking, and the emerging Golden Dome / Space-Based Interceptor missile-defense architecture. Barriers are high (ITAR, security clearances, flight heritage), and there is an explicit policy intent to displace slow legacy primes with “new primes” (Rocket Lab, Anduril, Palantir). This segment is already two-thirds of Rocket Lab’s revenue and is where its structural position is strongest.

3.2 The SpaceX shadow

Any honest industry analysis must center SpaceX. In 2025 SpaceX flew 165 Falcon launches (a record, roughly one every other day), held ~82% of global commercial launch share, and generated ~$18.7B of revenue (Starlink ~$11.4B of it, ~61%, at ~$4.4B operating profit). Critically, ~123 of those 165 launches were internal Starlink missions — SpaceX is its own largest customer, a self-reinforcing demand-and-cost flywheel Rocket Lab cannot replicate. SpaceX priced its IPO at ~$1.75T (~June 11–12, 2026), directly into this report’s window — the largest IPO in history, and a sentiment event whipsawing the entire space sector, with RKLB as the lead public proxy.

3.3 Barriers to entry

Barriers are high and favor incumbents: enormous capital intensity, the multi-year accumulation of flight heritage, ITAR/regulatory hurdles, scarce launch-range access, and — in Space Systems — security clearances and program track record. Beck’s claim that Rocket Lab is “one of only two companies in history” to scale a new orbital rocket to reliable high cadence (the other being SpaceX) is defensible and material. Vertical integration across engines, composites, avionics, payloads, optics, and propulsion is itself a multi-year, multi-acquisition moat that is hard to replicate at speed.

Verdict (Industry Dynamics): A bifurcated industry. Rocket Lab’s destination markets — medium launch and defense space systems — are structurally attractive (large, growing, high-barrier, policy-supported). But its current revenue base still leans on the weakest sub-market (small launch) plus lumpy government programs, and it competes everywhere in the shadow of a vertically-integrated, internally-demand-fed, now-public SpaceX whose marginal economics it cannot match. Structurally good destinations; a very tough competitive frame.

4. Competitive Position

4.1 Naming the moat

Applying Greenwald’s taxonomy (the relevant lens is barriers to entry that produce durable, financially-visible advantage), Rocket Lab’s competitive position decomposes into two very different stories.

Electron / small launch — a genuine but low-value advantage (intangible / flight-heritage, within a niche). With ~70+ missions and the only reliable high-cadence dedicated smallsat capability after the competitive field collapsed, Electron has a real reputational/heritage moat. But — and this is the Greenwald test that matters — an advantage that protects only a small, rideshare-capped, modest-profit pool is a weak moat. Electron’s leadership is durable but low-value: a beachhead, not the thesis. Its economics are now genuinely good (segment gross margin reached 44% in Q1 2026), but it is only a third of revenue and inherently lumpy.

Space Systems vertical integration — the strongest moat candidate (intangibles + emerging scale + supplier-of-choice positioning). The moat mechanism with an actual financial fingerprint is here. Management states the $816M SDA Tranche 3 win was secured because of vertical integration — owning the bus, payloads, solar, reaction wheels, star trackers, and optical-comms terminals lets Rocket Lab bid faster and at a cost structure legacy primes cannot match at the same margin. This is a testable moat claim: integration → cost/schedule-advantaged bids → wins, plus merchant component pull-through from the very competitors who beat it on the prime. Being simultaneously supplier to and rival of Lockheed/Airbus/Northrop is a structurally advantaged position — if the supplier relationships survive the competitive tension.

4.2 Pressure tests (the disconfirming evidence)

• No durable cost moat vs. SpaceX. Reusability plus internal Starlink demand give SpaceX a cost-and-cadence advantage Rocket Lab cannot replicate; Neutron is years and one un-flown vehicle away, and Starship threatens $/kg across all classes. Rocket Lab’s defense — not competing head-on on price, leaning on national-security and responsiveness niches, and refusing to discount Neutron — is defensible but share-limited.
• No network effects. Launch and satellites are not two-sided markets. The “ecosystem” is vertical integration, not a network effect. No network-effects moat should be credited.
• Switching costs are moderate, not high. Flight-heritage and qualification lock-in bind a customer within a program (no one re-qualifies a bus or payload mid-program), but at procurement time customers multi-source. The CFO confirms components like solar-array drives are bought from multiple suppliers. Switching costs bind within programs, not across procurements.
• The moat is partly bought. Eight-plus acquisitions assembled the integrated stack. Mynaric explicitly “needs a lot of work” and is margin-dilutive to Space Systems near-term; the largest backlog (SDA) is lower-margin. The moat is being acquired as much as built, and integration at this acquisition pace (GEOST + Mynaric + Motiv inside 12 months) is unproven.
• Customer/policy concentration. Heavy reliance on US-Government budgets (SDA, NSSL, Golden Dome); Lockheed >10% of receivables. Programs are “easily whipsawed” by administration changes (Beck’s own words regarding NASA’s Gateway).

Verdict (Competitive Position): A real but still-emerging moat, concentrated in Space Systems vertical integration — not a wide moat, and not in launch. Electron’s small-launch leadership is durable but low-value. The credible, financially-visible moat is the integrated satellite stack (evidenced by the SDA Tranche 3 win and the dual supplier/prime position), but it is partly acquired, margin-dilutive near-term, defense-funding-dependent, and unproven at the current acquisition cadence. Crucially, the entire bull narrative ultimately rests on Neutron — an unflown, repeatedly-delayed vehicle entering a concentrated medium-launch market dominated by a far cheaper, now-public SpaceX.

5. Growth History and Forward Opportunities

5.1 Historical growth

Revenue has compounded at roughly 76% annually over five years (off the ~$35M 2020 base), with management noting revenue is up nearly 10x since the 2021 listing. The growth is a blend of organic (Electron cadence, HASTE, organic Space Systems) and acquired (the components roll-up). Q1 2026 revenue of $200.3M was the first $200M+ quarter and grew 63.5% year over year — an acceleration, driven by Space Systems (+57%) and a reaccelerating Launch line (+79%).

5.2 Growth drivers and forward opportunities

• Electron + HASTE: Management guides ~20% annual growth in the combined launch line, with factory capacity (52/yr) and three pads providing headroom. HASTE (hypersonics) is the fastest-growing leg and carries higher ASPs.
• Space Systems / SDA: The two SDA prime awards (~$1.3B combined) dominate the Space Systems backlog. These are large but back-loaded and lower-margin. Continued prime wins (and the merchant pull-through) are the organic engine.
• Neutron: The central catalyst. List price ~$50–55M/launch; the Q1 2026 “largest contract in company history” (5 Neutron + 3 Electron for a confidential customer) was priced “in family with commercial rates.” Revenue is a 2027-and-beyond story, contingent on a Q4 2026 first flight holding.
• Golden Dome / missile defense: Rocket Lab was selected with Raytheon for a Space-Based Interceptor demonstration; HASTE is positioned for threat-simulation testing; the SDA Tracking Layer is core to the architecture. Management frames this as a “very large opportunity,” but it is gated, partly self-funded, and currently demo-scale — the dollar magnitude and timing are open questions.
• Europe / international: The Mynaric acquisition establishes a European beachhead into a growing sovereign-space market.
• “Services from space” / own constellation (Flatellite): Management’s stated end-game and largest TAM, but explicitly deferred until Neutron is flying. Pure optionality today.

Verdict (Growth): High top-line growth of mixed quality. It is real, fast, accelerating, and increasingly diversified, and the competitive position behind it is genuine. But (a) it is subsidized by perpetual equity dilution and deep cash burn, not self-funding; (b) the highest-margin future (Neutron reuse economics, services) is unproven optionality, while the largest current backlog (SDA) is lower-margin, lumpy, government-concentrated, and subcontractor-gated; and © Space Systems growth is partly bought. This is high-quality engineering execution attached to not-yet-proven unit economics — the moat-to-financial-outcome link is still prospective.

6. Financial Quality

6.1 The two-speed margin structure

The consolidated 34.4% FY2025 gross margin hides a two-speed business:

Three observations:

1. Launch margins have inflected hard — from 11% to 44% in two years — as Electron cadence rises and fixed costs are absorbed, ASPs climb, and higher-value HASTE revenue mixes in. This is the genuine “economics improve with scale” evidence.
2. Space Systems is the larger but lower-margin segment, and the revenue-mix shift toward large SDA constellation work (which the CFO says comes in “at the low end of our gross-margin mix”) is a structural headwind partially offsetting Electron’s tailwind. The long-term 50%+ corporate gross-margin target the valuation needs depends heavily on Neutron and on merchant-component mix, not on the SDA work that dominates today’s backlog.
3. The improvement is concentrated in the smaller segment.

6.2 Below gross profit: the R&D and cash-burn problem

The real problem is below gross profit:

• Operating loss FY2025 −$228.8M (−38% of revenue), wider in absolute dollars than FY2024 (−$189.8M) but narrowing as a percentage (−73% → −44% → −38%). Q1 2026 operating loss was −$56.0M (−27.9%), a meaningful improvement on Q1 2025 (−48.3%).
• The wedge between improving gross margin and a still-large dollar operating loss is R&D: $270.7M in FY2025 = 45% of revenue (Q1 2026: $80.5M, 40%). This is almost entirely Neutron. Management states Q1 2026 was “peak Neutron R&D” and expects the spend to roll into flight inventory through 2026.
• Net loss FY2025 −$198.2M, but this was flattered by a $27.7M tax benefit tied to the release of a valuation allowance from the GEOST acquisition. Normalizing that out, the pre-tax loss was −$225.9M; the headline “net loss only widened ~$8M YoY” understates the underlying operating deterioration.

6.3 Cash flow, liquidity, and runway

• FY2025: operating cash flow −$165.5M, capex $156.3M → free cash flow −$321.8M. Q1 2026 FCF ~−$77M. Run-rate burn is ~$300–400M/year and rising into Neutron’s first flight.
• Liquidity: ~$1.38–1.47B of cash and marketable securities at Q1 2026. Debt has been essentially eliminated — only ~$37.6M of 2029 convertible notes remain (≈88% converted to equity), and the Trinity loan was extinguished.
• Runway: roughly four years of burn before M&A outlays on the balance-sheet alone — but the company does not rely on the balance sheet. It funds the burn with continuous ATM equity issuance. Management’s “12 months covered” assertion is technically true but understates the real funding mechanism, which is dilution.

6.4 Quality of earnings

Generally clean, with caveats:

• R&D is expensed, not capitalized — conservative; no capitalized-software games inflating earnings.
• SBC is high but disclosed: $71.1M FY2025 (11.8% of revenue); a one-time $11.2M RSU-cancellation charge hit Q1 2026 SG&A. It is a real economic cost that the company-defined Adjusted EBITDA strips out.
• Acquired intangibles are large: GEOST contributed $172.3M of developed-technology intangibles (a critical audit matter), plus ~$209M of Space Systems goodwill — future amortization drag and impairment exposure if national-security revenue disappoints.
• Adjusted EBITDA turned only modestly negative (Q1 2026 −$11.8M, beating the −$21M to −$27M guide), and management frames Adjusted-EBITDA breakeven as plausibly 2026–27. But Adjusted EBITDA ≠ GAAP profit; there is no management line of sight to GAAP operating-income breakeven, which is not a FY2026 or likely FY2027 event.

6.5 Returns on capital

With a net loss of −$198.2M on ~$2.26B of equity, ROE is ~−9%; ROIC is deeply negative. With persistent operating losses and a full valuation allowance on US deferred tax assets, return metrics are not meaningful and will stay negative until Neutron scales. There is no return-on-capital case yet — only a revenue-growth-and-margin-trajectory case.

Verdict (Financial Quality): Economics are improving at the gross-margin line, and Electron’s unit economics are now genuinely good. But the improvement is concentrated in the smaller segment; the larger segment is lower-margin and mix-pressured; and below gross profit the company is a ~$300–400M/year cash-burner funded by dilution, with GAAP profitability nowhere on the visible horizon. Good trajectory, no profits, real burn.

7. Capital Allocation

7.1 The funding machine: equity, not debt

Since the 2021 de-SPAC (~$777M gross), Rocket Lab has funded itself almost entirely with equity:

• February 2024: $355M of 4.25% convertible senior notes due 2029, with a capped call to limit dilution. With the stock running from ~$8 to $60–140, holders converted almost the entire issue to equity — only ~$37.6M (11%) remains, and the capped call is now deep in the money.
• ATM equity — the real engine: a $500M March 2025 program (terminated) and a $750M September 2025 program. FY2025 ATM issuance: 30.8M shares for ~$1,119M net. Q1 2026: 6.36M shares for ~$445.6M net. Plus an April 2026 collared-forward sale of 7.45M shares (~$474–642M expected). Cumulative ATM/forward raised in ~15 months: ~$1.6B+ net.

The form of this is defensible — management used cheap converts plus a capped call in 2024, then pivoted to high-priced ATM issuance in 2025–26, selling stock into strength at $40–140 to fund a pre-profit business at a >$60B valuation. The substance is unambiguous, heavy, ongoing dilution.

7.2 Dilution, quantified

Weighted-average shares: 481.8M (FY2023) → 495.9M (FY2024) → 530.7M (FY2025). Cover-page shares: 534.2M (Nov 2025) → 567.4M (Feb 2026) → 578.8M (Apr 2026). Management guides toward ~605M basic weighted shares in Q1 2026. That is 20%+ share-count growth in ~18 months from ATM issuance, convertible conversions, and SBC. No buybacks — appropriately, for a cash-burning issuer.

7.3 M&A — the strongest part of the story

The M&A program is strategically coherent and cheap. Each deal pulls a constrained, high-value spacecraft sub-system in-house, converting merchant supply into captive supply at scale prices and feeding the national-security stack. Mynaric is a notably opportunistic, distressed purchase — Rocket Lab acquired leading laser-comms technology at a low ~$75M base price out of a German restructuring, classic capital-cycle opportunism. Prices are small relative to the ~$62B market cap. The risks are integration (three deals inside 12 months), the $172M GEOST intangible’s impairment exposure, and earnouts that could expand cost.

7.4 Incentive alignment (proxy)

• CEO Peter Beck 2025 pay: $800K salary + $6.03M time-based RSUs + $0 bonus = ~$6.83M (down from ~$20.1M in FY2024). Other NEOs received modest cash and minimal 2025 equity; certain executives forwent 2025 bonuses.
• A genuine design red flag: the proxy states outright that no NEO incentive program is based on any specific financial criteria, and there is no formal bonus program. All NEO equity is time-based RSUs — no performance conditions, no operational milestones (e.g., Neutron first flight, margin, FCF), no TSR-linked vesting. There is no contractual link between pay and outcomes.
• Ownership and control: Beck beneficially owns ~46.4M shares (~7.5% of voting power). In late 2024/early 2025 he exchanged ~51M common shares into Series A Preferred held by his family trust — a control device that votes with common on an as-converted basis, lets him elect at least one director (himself), and converts to common only if he ceases to be CEO, dies/is disabled, transfers, or drops below 5%. This is effectively a founder-control/dual-class-lite structure that entrenches his board seat independent of his economic stake — a governance negative for minorities, though common in founder-led tech.

The alignment verdict is “aligned by ownership, not by contract”: Beck has ~$3B+ of stock and an enormous incentive to maximize share value, but the formal pay design is weak and the control structure reduces accountability.

7.5 Insider activity

The Form 4 record (Dec 2024–Jun 2026) is striking: zero open-market purchases by any insider in 18 months, against ~$537.6M of sales — Beck ~$270.6M, CFO Adam Spice ~$164.3M, with the remainder across other officers and directors. About 84% of sales were under Rule 10b5-1 plans (diversification, not panic), and against Beck’s ~46M-share stake $271M is a partial trim. But the complete absence of any buying, combined with hundreds of millions sold into strength, is a clear “insiders see the stock as fully-to-richly valued” signal at ~90x sales.

Verdict (Capital Allocation): Mixed-to-favorable. Positives: cheap, coherent, on-strategy M&A; smart financing (converts + capped calls, then high-priced ATM); debt essentially eliminated; ample liquidity. Negatives: 20%+ dilution in 18 months with more coming; no line of sight to self-funding; weak performance-pay design; a founder-control structure; and heavy insider selling. Management is allocating capital intelligently given its constraints, but shareholders pay through relentless dilution, and the verdict cannot be “good” until the spend produces returns.

8. Changes and Headwinds — Last Two Years

Verdict (Changes/Headwinds): Net, recent changes strengthen the strategic and competitive position — bookings, prime wins (SDA T3, SBI/Golden Dome, Anduril), vertical-integration completeness, and consistent guidance beats are genuine and improve the long-run franchise. But the single most important near-term item — Neutron — slipped and suffered a structural test failure, and the unflown program underpins ~75–80% of the EV. Growth and M&A remain dilution-funded, and the current valuation rally is amplified by SpaceX-IPO sentiment rather than a fundamental re-rating. The thesis is qualitatively stronger and quantitatively more demanding than two years ago.

9. Risk Analysis

Summary: The dominant risks are Neutron execution and valuation — and they are linked, because the multiple is underwriting Neutron. The realistic adverse scenario is not bankruptcy (the balance sheet is strong) but a severe de-rating on a Neutron stumble or a “sell-the-SpaceX-IPO-news” unwind.

10. Valuation Discussion (Embedded Expectations)

No price target, no recommendation. This section analyzes only what the current price implies.

10.1 The starting multiple

At ~$61.4B EV on $679.6M TTM revenue, RKLB trades at ~90x EV/Sales (~102x on FY2025; ~67x on FY2026E consensus of ~$914M). Price/book is ~28x. On its own ten-year history, P/S sits in the 86th percentile and P/B in the 76th — expensive versus its own past, though below the 2021 SPAC-bubble peak. Consensus models loss-making results until ~2027 breakeven and a first GAAP profit (~$176M) around 2028. Consensus price targets cluster near the current price (~$104–105), and analyst ratings skew positive (roughly 7 strong-buy / 3 buy / 5 hold of ~15 covering).

10.2 Reverse-DCF / scenario analysis

To justify today’s ~$61.4B EV, an investor needs a future enterprise value that compounds at an acceptable rate. At a ~12% cost of capital, ~$61.4B must grow to ~$108B by FY2030 (4.5 years) merely to earn 12%; to deliver the ~20%+ that growth-equity holders implicitly want, the FY2030 EV must reach ~$150B. The grid below shows what various FY2030 outcomes imply:

The conclusion is stark: even a strong bull case (revenue 8x in five years to $5B, an 18% FCF margin, and a rich 15x exit) produces only ~$75B of EV — barely above today, and below the level needed to compensate for risk. To merely earn a market return from here, RKLB must approach a ~$7.5B-revenue, >20%-FCF-margin, premium-multiple outcome by 2030 — i.e., become a materially larger, profitable, reusable-launch-plus-space-prime-plus-services platform.

10.3 Decomposing the EV

Roughly:

• Electron + current Space Systems — the proven, ~$680M-TTM, ~30–40%-growing, ~38%-GM (but SDA-mix-pressured) business — on a generous 10–15x forward-sales basis is worth perhaps $10–15B of EV.
• The residual ~$45–50B (≈75–80% of EV) is Neutron + SDA scale-up + the merchant/vertical-integration franchise + Golden Dome + services optionality. Neutron must fly, prove reuse, hit ~$50–55M ASPs at cadence, and convert backlog into profitable, self-funding cash flow.

10.4 The SpaceX cross-check

The common bull claim that “RKLB is cheap relative to SpaceX” is false on a sales-multiple basis. SpaceX’s ~$1.75T IPO valuation on ~$18.7B of 2025 revenue is ~93x trailing sales — essentially the same multiple as RKLB’s ~90x — but SpaceX is FCF-generative (Starlink), flies a reusable fleet, and dominates the market. The bull argument is therefore not relative value; it is a TAM/optionality bet that a $62B RKLB can grow into a fraction of a $1.75T SpaceX. Against traditional A&D (Lockheed/L3Harris at ~3x EV/Sales, ~17x EV/EBITDA), RKLB trades at ~30x the sales multiple — the entire valuation is a bet it does not become a normal defense contractor.

10.5 What the market is pricing correctly vs. incorrectly

• Correctly: execution credibility (Electron reliability, on-time HASTE, ESCAPADE-to-Mars, repeatable SDA prime wins); a genuine vertical-integration moat; the secular defense/space tailwind; and the scarcity value of being one of two Western firms that can build a reusable medium rocket.
• Possibly incorrectly: treating Neutron success as near-certain when no Neutron has flown and a Stage-1 tank already ruptured; capitalizing 2030+ “services” TAM that management itself calls premature; under-weighting the per-share drag of perpetual dilution; and assuming a ~38% / SDA-heavy margin mix re-rates quickly toward the 50%+ target the valuation needs.

Verdict (Valuation): The price embeds a base-to-bull “next-platform” outcome as the base case. The reverse-DCF shows even a strong bull case struggles to clear a market-return hurdle, and ~75–80% of EV is Neutron/optionality rather than the in-hand business. The valuation is not a relative-value opportunity versus SpaceX; it is a high-conviction bet on flawless, multi-year, multi-front execution.

11. Variant Perception

Consensus belief: RKLB is “the next SpaceX” — the only credible Western vertically-integrated end-to-end space platform, disrupting legacy A&D primes, with Neutron about to unlock medium-lift, constellation deployment, and eventually in-orbit services. The buy-side treats it as the #1 public proxy for the SpaceX IPO wave.

Strongest bull case: One of only two Western firms ever to field a reliable, high-cadence orbital rocket; Neutron extends that to a Falcon-9-starved medium-lift market; repeated prime wins (SDA T2/T3, ~$1.3B) prove the disruption is real; vertical integration delivers structural cost/schedule advantage plus merchant revenue from competitors’ programs; a massive optionality stack (Golden Dome/SBI, Europe, Mars, own constellation/services); and peak Neutron R&D passing into an operating-leverage and cash-flow inflection.

Strongest bear case: ~90x sales / ~28x book, deeply loss-making, FCF −$322M, ~75–80% of EV unproven; the same sales multiple as a profitable, fleet-flying SpaceX; Neutron unflown and already slipped after a tank rupture, with reuse (the whole economic thesis) untested until Flight 2+; SpaceX/Starship crushing launch economics and Starlink/MILNET potentially eroding the constellation TAM; perpetual dilution funding the burn; and a low-margin, lumpy, government-concentrated backlog far from the 50%+ GM the valuation needs.

The assumptions that matter most, and their falsification tests:

1. Neutron reaches reliable, reusable cadence at ~$50–55M ASP. Falsifies the bull: a Flight-1 loss or further multi-quarter slip, or reuse not demonstrated by ~2027. Falsifies the bear: a clean Q4 2026 orbital flight plus successful Flight-2 reuse with ASP holding.
2. Space Systems scales to platform economics, not commodity government work. Falsifies the bull: GM stalls below ~40% as SDA mix dominates. Falsifies the bear: GM trending toward 45–50% with merchant pull-through.
3. The company reaches self-funding cash flow before dilution erodes the thesis. Falsifies the bull: continued ATM raises and FCF burn through 2027–28 with no inflection. Falsifies the bear: Adjusted EBITDA turns positive in 2026 (already tracking ahead) and FCF inflects post-Neutron.
4. SpaceX/Starlink do not foreclose the medium-lift + constellation TAM. Falsifies the bull: Starship/Starlink price-competes RKLB out. Falsifies the bear: sustained third-party demand for non-SpaceX assured access (already visible in international Electron bookings and the 5-launch Neutron deal).
5. Defense/Golden Dome spend converts to large RKLB revenue. Falsifies the bull: SBI/Golden Dome stays demo-scale or is budget-cut. Falsifies the bear: multi-hundred-million production awards land.

The genuine variant perception is not “is this a good company?” — consensus and skeptics largely agree it is the best-executing Western pure-play. It is “does ~$62B already capitalize 5+ years of flawless, multi-front execution, leaving negative skew?” With consensus targets at roughly the current price and short interest only ~5.8% of float, the market is not positioned bearishly — there is no crowded short to squeeze, and the asymmetry on a Neutron stumble or a “sell-the-SpaceX-IPO-news” unwind is to the downside. The contrarian stance here is valuation discipline, not company skepticism.

12. Fact vs. Interpretation Table

13. Open Questions

1. Neutron unit economics at scale — actual realized ASP, reusability refurbishment cost, and gross margin on the first revenue flights (2027). The whole thesis rests here.
2. FY2027–FY2030 revenue path — consensus beyond FY2026 is thin/paywalled; the reverse-DCF is sensitive to it.
3. Golden Dome / SBI dollar magnitude and timing — demo-scale today; what converts to production, and when?
4. SDA Tranche 3 merchant-capture — how close does it get to the ~$1B ceiling, and at what margin?
5. Pace of future dilution — how many more shares fund the M&A pipeline and burn before FCF inflects?
6. Government/commercial revenue split — not cleanly disclosed; directionally majority-government and rising.
7. Mynaric/GEOST integration and intangible impairment risk — does the acquired stack deliver the modeled margins?

14. What Must Be True

For the bull case to be right:

• Neutron must fly cleanly in ~Q4 2026 and demonstrate booster reuse on Flight 2, at ASPs holding ~$50–55M, scaling toward a meaningful annual cadence by 2028–29.
• Space Systems gross margin must trend toward 45–50% (merchant mix + platform economics), not stall in the low-30s under SDA weight.
• The company must reach self-funding cash flow (FCF inflection) before dilution materially erodes per-share value.
• Defense spend (Golden Dome/SBI, SDA scale-up) must convert from demos to large production awards.
• Falsification test: a Neutron Flight-1 loss or another multi-quarter slip; or gross margin stuck below ~40% through 2027; or continued ATM raises with no FCF inflection by 2027–28. Any one materially breaks the bull case.

For the bear case to be right:

• Neutron must keep slipping or fail; and/or the valuation must compress as the market re-rates ~90x sales toward something defensible; and/or SpaceX/Starship must foreclose the medium-lift and constellation TAM.
• Falsification test: a clean Neutron orbital flight + successful reuse + ASP discipline (de-risks ~80% of EV); Adjusted-EBITDA turning sustainably positive in 2026; and continued prime wins that legacy primes cannot match. A successful, reusable Neutron is the single fact that most undermines the bear case.

The crux for both sides is the same unflown rocket. That concentration of thesis-determining risk in one binary, repeatedly-delayed event — against a ~90x-sales valuation — is the defining feature of the investment.

15. Source Appendix

See the Source Appendix below for the full, dated, primarily-primary source list. Principal sources: Rocket Lab FY2021–FY2025 Forms 10-K; Q1 FY2026 Form 10-Q (filed 2026-05-07); DEF 14A (filed 2026-04-06); the SEC EDGAR Form 4 insider-transaction corpus (CIK 1819994); quarterly earnings-call transcripts (Q3 2025, Q4 2025, Q1 2026) and the May 2025 M&A call; SEC EDGAR XBRL data for financial reconciliation; and public trade/financial press for industry sizing, competitor facts, and the June 2026 SpaceX IPO. Management commentary was treated throughout as a hypothesis requiring external validation against filings and data.

This article is independent fundamental research for general information only and is not investment advice. The analytical body takes no investment position and sets no price target; the sole expression of opinion is the labeled “Claude’s Take” block, which is the author’s own subjective view.

APPENDIX A — Standard Diligence Questionnaire

RKLB — Standard Diligence Questionnaire Appendix

Rocket Lab Corporation (NASDAQ: RKLB) · 2026-06-10 Supplemental to the research memo. Fact / Interpretation / Assumption labels applied where it matters.

General

What thoughtful questions have other investors asked about this company? The recurring institutional questions are: (1) Can Neutron actually fly on time and prove reusability? — the single most-asked question, given the slip history and the Jan 2026 tank rupture. (2) Is the valuation (~90x sales) justifiable, and how much is “next SpaceX” hope? (3) How dilutive is the perpetual ATM issuance, and when does the company self-fund? (4) Are the SDA prime wins durable and profitable, or low-margin government work that legacy primes ceded? (5) Does vertical integration actually translate into a margin/win-rate advantage, or is it an expensive roll-up? (6) What happens to the stock when SpaceX is publicly investable (post-IPO)? These map directly to this article’s “What Must Be True” section.

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Fact: There are no earnings — the company is loss-making (FY2025 net loss −$198.2M). The relevant cycle is the capital cycle: Rocket Lab is in a heavy-investment phase (Neutron R&D 45% of revenue), which by definition depresses current profitability. Interpretation: margins are at a structurally low point relative to the company’s own long-term target; the question is whether the post-Neutron normalization the valuation assumes actually arrives.

Driven by the external environment or internal actions? Both. Internally: deliberate R&D/capex spend on Neutron and acquisitions. Externally: defense-budget tailwinds (SDA, Golden Dome) and SpaceX-driven sector sentiment. The losses are overwhelmingly a choice (R&D), not a demand shortfall.

How stable are revenues? Fact: Lumpy. Launch revenue is uneven (point-in-time recognition; few launches per quarter), and Space Systems is dominated by large, back-loaded, milestone-gated government programs. Backlog ($2.2B) provides visibility but not smoothness.

Outlook for products/services? Growing: ~20% guided annual growth for Electron/HASTE; Space Systems scaling on SDA; Neutron a 2027+ revenue engine. Consensus revenue ~$914M FY2026E.

How big will this market be? Fact (cited): small-launch ~$3.5B→~$5.8B (2030); medium/heavy launch ~$15.6B→~$32B (2030); the satellite/defense-space pool is larger and faster-growing (proliferated-LEO, missile defense). Interpretation: the destination markets are large and growing; the current revenue base leans on the smallest of them plus government programs.

Business Quality & Competitive Moat

Is the industry getting more or less competitive? Mixed. Small launch is less crowded (rivals failed/exited) but rideshare-capped. Medium launch is concentrating around ~3 viable vehicles but is dominated by SpaceX. Defense space systems is opening to “new primes” (a tailwind for RKLB) but remains contested by Lockheed/Northrop/L3Harris.

How profitable is the business (ROIC, ROE)? Fact: Negative. ROE ~−9%; ROIC deeply negative; full valuation allowance on US deferred tax assets. Not meaningful until Neutron scales. The correct read is gross-margin trajectory (21%→38%) and segment unit economics (Launch GM 44% in Q1’26), not return-on-capital, which does not yet exist.

How profitable is the industry — competitors, barriers? Launch is a hard business (SpaceX is the only consistently profitable launcher, via Starlink self-supply). Barriers are very high (capital, heritage, ITAR, range access). Defense space systems can be attractive at scale for vertically-integrated bidders.

Can the business be easily understood? Reasonably — two segments, transparent segment reporting. The hard part is not understanding the business but valuing optionality (Neutron, services).

Can it be undermined by foreign low-cost labor? No, in the relevant sense. US national-security launch and satellite work is ITAR-protected and clearance-gated; foreign labor arbitrage is not the competitive threat. The threat is a domestic incumbent (SpaceX) with structurally lower costs.

Do brands matter? Not as consumer brands, but flight heritage and reliability reputation function as a B2B/B2G brand and are a genuine intangible asset (Electron’s track record; the “only two companies in history” framing).

Nature of competition / switching costs? Competition is on reliability, schedule/responsiveness, price, and (in Space Systems) integrated capability. Switching costs are moderate: high within a qualified program, low across procurements (customers multi-source components).

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? Interpretation: Yes, economically — flight heritage, the integrated engineering organization, and IP developed via expensed R&D are not capitalized. Conversely, acquired developed-technology intangibles ($172.3M from GEOST) are on the balance sheet and carry impairment risk.

Off-balance-sheet liabilities? Operating leases (launch sites, facilities) and acquisition earnouts (GEOST up to $50M, Motiv up to $20M, contingent consideration). The capped call on the 2024 converts is an asset (deep in the money). No unusual hidden leverage identified.

How conservative is the accounting? Reasonably conservative. R&D is expensed (not capitalized); SBC is disclosed and large; the company-defined Adjusted EBITDA strips real costs (SBC, D&A) and should be discounted. The one flattering item to normalize is the FY2025 $27.7M tax benefit. Revenue recognition (point-in-time vs. over-time) is standard for the sector.

How CapEx-hungry is the business? Very. FY2025 capex $156.3M (Neutron production, Launch Complex 3, factory expansion) on top of $270.7M R&D. This is a peak-investment phase; capex should moderate as a % of revenue post-Neutron, but the business is structurally capital-intensive.

Capital Allocation & Management

How much FCF does the business generate; how is it used; what is the philosophy? Fact: Negative FCF (−$321.8M FY2025). There is no FCF to allocate; the philosophy is invest-for-growth, funded by equity. Cash goes to Neutron R&D, capex, and acquisitions.

Significant acquisitions recently? Yes — GEOST ($275M, payloads, Aug 2025), Mynaric (~$155.3M, laser comms, Apr 2026), Motiv (~$40M, robotics, May 2026), plus earlier SolAero/Sinclair/PSC/ASI. A coherent vertical-integration roll-up at generally cheap prices; the strongest part of capital allocation.

Buying back shares? No — and appropriately not, for a cash-burning issuer.

Issuing large amounts of new shares to insiders? Equity issuance is dominated by ATM market sales (~$1.6B+ in 15 months) and convertible conversions, not insider grants per se, though SBC ($71.1M, 11.8% of revenue) is high. Share count is up 20%+ in 18 months.

Compensation policy of directors/management? Fact / red flag: NEO incentive comp has no performance or financial criteria; there is no formal bonus program; all NEO equity is time-based RSUs. CEO 2025 pay ~$6.83M. Interpretation: weak pay-for-performance design, partly mitigated by Beck’s enormous (~$3B) equity stake.

Motivations of management? Interpretation: Founder-led (Peter Beck), mission-and-equity-driven. Aligned by ownership, not by contract. The Series A Preferred control structure entrenches Beck’s board influence beyond his economic stake — a governance negative.

Valuation & Market Data

Is the stock an ADR, MLP, or K-1 issuer? Fact: No. RKLB is a US domestic C-corporation common stock listed on Nasdaq (files 10-K/10-Q). No K-1; standard 1099 treatment.

Dividend policy? None, and none expected — the company reinvests all capital and burns cash.

How profitable is the business? Not profitable (see above). Gross margin 38% and rising; operating and net margins negative.

Is net income diverging from cash from operations? Fact: Both are deeply negative and broadly directionally consistent. FY2025 net loss −$198.2M vs. operating cash flow −$165.5M; the gap reflects non-cash add-backs (SBC, D&A) offset by working-capital and the tax benefit. The larger divergence is between Adjusted EBITDA (near-breakeven) and GAAP net loss — the gap is SBC, D&A, and Neutron R&D framed as “investment.”

Risks & Downside

What factors would cause the stock to decline? A Neutron Flight-1 failure or further multi-quarter slip; a valuation de-rating from ~90x sales; a “sell-the-SpaceX-IPO-news” sentiment unwind; gross margin stalling under SDA mix; a large dilutive raise; or a government-budget/program disappointment. (See risk matrix, .)

Risk of a catastrophic loss? Low near-term. ~$1.4B liquidity, negligible debt, and a diversified launch + space-systems + components base make insolvency unlikely on any near horizon. The realistic severe-downside scenario is a large multiple compression, not a wipeout.

Chance of a total loss? Low. The combination of strong liquidity, real (if unprofitable) revenue, hard assets, and strategic value to the US defense base makes total loss improbable. The investment risk is overpayment, not bankruptcy.

Recent News & Events

Has the business environment changed recently? Yes, materially. The SpaceX IPO (~$1.75T, ~June 12, 2026) has re-rated the entire space sector and made SpaceX directly investable — a double-edged event for RKLB (sentiment tailwind now, potential competition for capital and a “sell-the-news” risk). Defense-space spending is broadening (Golden Dome, SDA Tranche 3).

Significant acquisitions? GEOST, Mynaric, Motiv (2025–26) — see Capital Allocation.

Change in accounting policies? None material identified beyond ordinary acquisition accounting and the GEOST-related valuation-allowance release.

Recent changes — new markets, facilities, management? Renamed “Rocket Lab Corporation” to reflect international (European) expansion; new optics/robotics/laser-comms capabilities via M&A; Launch Complex 3 and Neutron production build-out; the Beck Series A Preferred control structure established. No CEO/CFO turnover; certain executives forwent 2025 bonuses.

Frameworks applied: Greenwald (barriers-to-entry / moat taxonomy — the genuine advantage is Space Systems vertical integration, not launch) and Marathon capital-cycle (heavy capital-deployment phase; opportunistic distressed M&A such as Mynaric; the test is whether high-return normalization actually arrives post-Neutron).

APPENDIX B — Source Appendix

RKLB — Source Appendix

Rocket Lab Corporation (NASDAQ: RKLB) · Research date 2026-06-10 Primary sources first. All web sources accessed 2026-06-10 unless noted. Third-party data feeds were used as quantitative cross-checks and reconciled to SEC filings; management commentary treated as hypothesis requiring external validation.

A. SEC filings (primary — EDGAR, CIK 0001819994)

B. Earnings-call & event transcripts (primary management commentary)

C. Industry, competitor & market data (secondary — public)

• Small-lift launch market sizing (~$3.5B→~$5.8B by 2030): Verified Market Reports.
• Medium/heavy-lift launch sizing (~$15.6B→~$32B by 2030): 360iResearch; medium-class viable-vehicle count: SpaceWorks-type analysis.
• SpaceX 2025 operating data (165 launches, ~82% commercial share, ~$18.7B revenue, Starlink ~$11.4B): Space.com; Morningstar; Sacra.
• SpaceX IPO (~$1.75T valuation, ~$135/share, Nasdaq debut ~June 11–12, 2026): CNBC (2026-06-03); Fortune (2026-06-06).
• Neutron status / Jan 2026 tank rupture / Q4 2026 slip: The Register (2026-… coverage); Via Satellite / SatelliteToday (2026-02-27); NASASpaceFlight (2026-05); Wikipedia (Neutron rocket).
• NSSL Phase 3 Lane 1 on-ramp ($5.6B program ceiling): Rocket Lab press release (2025).
• Acquisition terms (GEOST, Mynaric, Motiv): BusinessWire (GEOST close, 2025-08-11); Via Satellite (Mynaric close, 2026-04-14); Payload (Motiv).
• Competitor reference: Firefly Alpha/Eclipse, Blue Origin New Glenn (May 2026 pad-test explosion), ULA Vulcan — Spaceflight Now, Wikipedia.
• Peer/sector multiples: stockanalysis.com (RKLB consensus forecast); Simply Wall St; Lockheed/L3Harris EV/Sales & EV/EBITDA (investing.com / financial press).
• Sector sentiment context (SpaceX-IPO proxy trade): Foreign Policy Journal (2026-06-10); WSJ (“More to space stocks than SpaceX”).